Published in Clin Infect Dis on December 06, 2013
PC4PrEP: Integrating PrEP Into Primary Care (PC4PrEP) | NCT03617874
HIV providers' perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study. AIDS Behav (2014) 2.00
Knowledge is Power! Increased Provider Knowledge Scores Regarding Pre-exposure Prophylaxis (PrEP) are Associated with Higher Rates of PrEP Prescription and Future Intent to Prescribe PrEP. AIDS Behav (2015) 1.49
Pre-exposure prophylaxis for sexually-acquired HIV risk management: a review. HIV AIDS (Auckl) (2015) 1.31
Intentions to prescribe preexposure prophylaxis are associated with self-efficacy and normative beliefs. Clin Infect Dis (2014) 1.20
Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV. AIDS Patient Care STDS (2014) 1.19
Knowledge, Beliefs and Practices Regarding Antiretroviral Medications for HIV Prevention: Results from a Survey of Healthcare Providers in New England. PLoS One (2015) 1.15
Antiretroviral pre-exposure prophylaxis implementation in the United States: a work in progress. J Int AIDS Soc (2015) 1.14
Antiretrovirals for primary HIV prevention: the current status of pre- and post-exposure prophylaxis. Curr HIV/AIDS Rep (2015) 1.04
Advances in HIV prevention for serodiscordant couples. Curr HIV/AIDS Rep (2014) 1.02
Oral pre-exposure prophylaxis (PrEP) for prevention of HIV in serodiscordant heterosexual couples in the United States: opportunities and challenges. AIDS Patient Care STDS (2014) 1.02
A Cross-Sectional Online Survey of HIV Pre-Exposure Prophylaxis Adoption Among Primary Care Physicians. J Gen Intern Med (2016) 1.00
Preparing for PrEP: perceptions and readiness of canadian physicians for the implementation of HIV pre-exposure prophylaxis. PLoS One (2014) 0.97
HIV providers' likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: a short report. AIDS Care (2016) 0.95
Clinical effectiveness and cost-effectiveness of HIV pre-exposure prophylaxis in men who have sex with men: risk calculators for real-world decision-making. PLoS One (2014) 0.95
Clinician attitudes toward CDC interim pre-exposure prophylaxis (PrEP) guidance and operationalizing PrEP for adolescents. AIDS Patient Care STDS (2015) 0.93
The role of healthcare providers in the roll out of preexposure prophylaxis. Curr Opin HIV AIDS (2016) 0.90
Pre-exposure prophylaxis to prevent HIV infection: current status, future opportunities and challenges. Drugs (2015) 0.90
Diffusion of Newer HIV Prevention Innovations: Variable Practices of Frontline Infectious Diseases Physicians. Clin Infect Dis (2015) 0.89
Preexposure prophylaxis-related stigma: strategies to improve uptake and adherence - a narrative review. HIV AIDS (Auckl) (2015) 0.87
How Stigma Surrounding the Use of HIV Preexposure Prophylaxis Undermines Prevention and Pleasure: A Call to Destigmatize "Truvada Whores". Am J Public Health (2015) 0.87
Understanding HIV Care Provider Attitudes Regarding Intentions to Prescribe PrEP. J Acquir Immune Defic Syndr (2015) 0.87
How could preventive therapy affect the prevalence of drug resistance? Causes and consequences. Philos Trans R Soc Lond B Biol Sci (2015) 0.86
Implementation of Preexposure Prophylaxis for Human Immunodeficiency Virus Prevention Among Men Who Have Sex With Men at a New England Sexually Transmitted Diseases Clinic. Sex Transm Dis (2016) 0.86
Putting PrEP into Practice: Lessons Learned from Early-Adopting U.S. Providers' Firsthand Experiences Providing HIV Pre-Exposure Prophylaxis and Associated Care. PLoS One (2016) 0.84
The Transition From Postexposure Prophylaxis to Preexposure Prophylaxis: An Emerging Opportunity for Biobehavioral HIV Prevention. Clin Infect Dis (2015) 0.84
Clinical Treatment Options Infectious Diseases: Update on PrEP Implementation, Adherence, and Advances in Delivery. Curr Treat Options Infect Dis (2015) 0.81
Preventing HIV among adolescents with oral PrEP: observations and challenges in the United States and South Africa. J Int AIDS Soc (2016) 0.81
Enhancing PrEP Access for Black and Latino Men Who Have Sex With Men. J Acquir Immune Defic Syndr (2016) 0.79
Reply to Sachdev et al. Clin Infect Dis (2014) 0.78
Preferences for HIV pre-exposure prophylaxis (PrEP) information among men-who-have-sex-with-men (MSM) at community outreach settings. J Gay Lesbian Ment Health (2015) 0.78
'PrEP is not ready for our community, and our community is not ready for PrEP': pre-exposure prophylaxis for HIV for people who inject drugs and limits to the HIV prevention response. Addiction (2016) 0.78
Adolescent Human Immunodeficiency Virus Care Providers' Attitudes Toward the Use of Oral Pre-Exposure Prophylaxis in Youth. AIDS Patient Care STDS (2016) 0.78
Values and Preferences on the Use of Oral Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Multiple Populations: A Systematic Review of the Literature. AIDS Behav (2016) 0.78
Framing HIV Pre-Exposure Prophylaxis (PrEP) for the General Public: How Inclusive Messaging May Prevent Prejudice from Diminishing Public Support. AIDS Behav (2016) 0.77
Self-reported Recent PrEP Dosing and Drug Detection in an Open Label PrEP Study. AIDS Behav (2016) 0.77
A novel Online-to-Offline (O2O) model for pre-exposure prophylaxis and HIV testing scale up. J Int AIDS Soc (2017) 0.76
The preexposure prophylaxis revolution: from clinical trials to routine practice: implementation view from the USA. Curr Opin HIV AIDS (2016) 0.75
Planning ahead for implementation of long-acting HIV prevention: challenges and opportunities. Curr Opin HIV AIDS (2015) 0.75
Knowledge, attitudes, and beliefs about HIV pre-exposure prophylaxis among US Air Force Health Care Providers. Medicine (Baltimore) (2016) 0.75
Pre-Exposure Prophylaxis: A Narrative Review of Provider Behavior and Interventions to Increase PrEP Implementation in Primary Care. J Gen Intern Med (2016) 0.75
A Medical Care Missed Opportunity: Preexposure Prophylaxis and Young Black Men Who Have Sex With Men. J Adolesc Health (2016) 0.75
PrEP Implementation Science: State-of-the-Art and Research Agenda. J Int AIDS Soc (2015) 0.75
Factors Related to Pre-exposure Prophylaxis Prescription by U.S. Primary Care Physicians. Am J Prev Med (2017) 0.75
Awareness and attitudes of pre-exposure prophylaxis for HIV prevention among physicians in Guatemala: Implications for country-wide implementation. PLoS One (2017) 0.75
Prescribing of Human Immunodeficiency Virus (HIV) Pre-exposure Prophylaxis by HIV Medical Providers in the United States, 2013-2014. Open Forum Infect Dis (2017) 0.75
Differentiating Nonoccupational Postexposure Prophylaxis Seroconverters and Non-Seroconverters in a Community-Based Clinic in Los Angeles, California. Open Forum Infect Dis (2017) 0.75
Preexposure Prophylaxis of HIV Infection: the Role of Clinical Practices in Ending the HIV Epidemic. Curr HIV/AIDS Rep (2017) 0.75
Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med (2011) 69.36
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med (2010) 50.17
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet (2008) 36.01
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med (2012) 27.84
Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med (2012) 20.03
Preexposure prophylaxis for HIV infection among African women. N Engl J Med (2012) 15.28
Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Sci Transl Med (2011) 5.21
Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR Morb Mortal Wkly Rep (2011) 4.85
Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention. AIDS (2012) 4.26
Trends in perinatal transmission of HIV/AIDS in the United States. JAMA (1999) 3.86
Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults. MMWR Morb Mortal Wkly Rep (2012) 2.95
Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence. Subst Use Misuse (2006) 2.83
A qualitative study of provider thoughts on implementing pre-exposure prophylaxis (PrEP) in clinical settings to prevent HIV infection. PLoS One (2012) 2.21
Preexposure prophylaxis for HIV infection: healthcare providers' knowledge, perception, and willingness to adopt future implementation in the southern US. South Med J (2012) 2.19
Dilemmas in the management of syphilis: a survey of infectious diseases experts. Clin Infect Dis (2009) 1.73
Update to Interim Guidance for Preexposure Prophylaxis (PrEP) for the Prevention of HIV Infection: PrEP for injecting drug users. MMWR Morb Mortal Wkly Rep (2013) 1.72
The promise of pre-exposure prophylaxis with antiretroviral drugs to prevent HIV transmission: a review. Curr Opin HIV AIDS (2013) 1.14
Perinatal HIV and its prevention: progress toward an HIV-free generation. Clin Perinatol (2010) 1.13
Estimating the cost-effectiveness of needle-syringe programs in Australia. AIDS (2012) 1.11
Early end for FEM-PrEP HIV prevention trial. AIDS Patient Care STDS (2011) 1.03
The Promise of Antiretrovirals for HIV Prevention. Curr Infect Dis Rep (2012) 1.02
Current management of prosthetic joint infections in adults: results of an Emerging Infections Network survey. Int J Antimicrob Agents (2013) 0.99
Knowledge of and opinions on HIV preexposure prophylaxis among front-line service providers at Canadian AIDS service organizations. AIDS Res Hum Retroviruses (2013) 0.95
The use of Twitter to track levels of disease activity and public concern in the U.S. during the influenza A H1N1 pandemic. PLoS One (2011) 6.92
Persistent GB virus C infection and survival in HIV-infected men. N Engl J Med (2004) 4.06
Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004. J Clin Microbiol (2007) 3.51
Detection and treatment of bloodstream infection: laboratory reporting and antimicrobial management. J Clin Microbiol (2003) 3.17
Staphylococcus aureus community-acquired pneumonia during the 2006 to 2007 influenza season. Ann Emerg Med (2008) 2.27
Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003. Clin Infect Dis (2005) 2.13
Monitoring hand hygiene via human observers: how should we be sampling? Infect Control Hosp Epidemiol (2012) 2.11
Disparities in smoke-free workplace policies among food service workers. J Occup Environ Med (2004) 2.08
Using sensor networks to study the effect of peripatetic healthcare workers on the spread of hospital-associated infections. J Infect Dis (2012) 1.99
Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005. Clin Infect Dis (2009) 1.73
Dilemmas in the management of syphilis: a survey of infectious diseases experts. Clin Infect Dis (2009) 1.73
The global transmission network of HIV-1. J Infect Dis (2013) 1.68
Percutaneous injury, blood exposure, and adherence to standard precautions: are hospital-based health care providers still at risk? Clin Infect Dis (2003) 1.53
Improving antimicrobial stewardship: the evolution of programmatic strategies and barriers. Infect Control Hosp Epidemiol (2011) 1.49
Are well-child visits a risk factor for subsequent influenza-like illness visits? Infect Control Hosp Epidemiol (2014) 1.42
Wide variability in the use of antimicrobial lock therapy and prophylaxis among infectious diseases consultants. Infect Control Hosp Epidemiol (2010) 1.40
Variability among pediatric infectious diseases specialists in the treatment and prevention of methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Pediatr Infect Dis J (2008) 1.39
Antimicrobial stewardship programs in pediatrics. Infect Control Hosp Epidemiol (2009) 1.38
Factors associated with drug-related harms related to policing in Tijuana, Mexico. Harm Reduct J (2011) 1.31
Chapter 3: Cohort life tables by smoking status, removing lung cancer as a cause of death. Risk Anal (2012) 1.31
The effect of cigarette price increases on smoking cessation in California. Prev Sci (2008) 1.30
Incidence of and risk factors for community-associated Clostridium difficile infection: a nested case-control study. BMC Infect Dis (2011) 1.29
Comparative study of rK39 Leishmania antigen for serodiagnosis of visceral leishmaniasis: systematic review with meta-analysis. PLoS Negl Trop Dis (2012) 1.26
The Infectious Diseases Society of America emerging infections network: bridging the gap between clinical infectious diseases and public health. Clin Infect Dis (2014) 1.23
Evaluating the impact of Mexico's drug policy reforms on people who inject drugs in Tijuana, B.C., Mexico, and San Diego, CA, United States: a binational mixed methods research agenda. Harm Reduct J (2014) 1.22
Toxicity of extended courses of linezolid: results of an Infectious Diseases Society of America Emerging Infections Network survey. Diagn Microbiol Infect Dis (2008) 1.19
Accuracy of phenotypic methods for identification of Streptococcus pneumoniae isolates included in surveillance programs. J Clin Microbiol (2008) 1.18
Clostridium difficile-associated diarrhea: an emerging threat to pregnant women. Am J Obstet Gynecol (2008) 1.18
Variability in pediatric infectious disease consultants' recommendations for management of community-acquired pneumonia. PLoS One (2011) 1.18
Identifying the HIV transmission bridge: which men are having unsafe sex with female sex workers and with their own wives or steady partners? J Acquir Immune Defic Syndr (2012) 1.16
Association between home smoking restrictions and changes in smoking behaviour among employed women. J Epidemiol Community Health (2006) 1.16
Decreasing prevalence of beta-lactamase production among respiratory tract isolates of Haemophilus influenzae in the United States. Antimicrob Agents Chemother (2005) 1.15
Cytomegalovirus DNA in semen and blood is associated with higher levels of proviral HIV DNA. J Infect Dis (2012) 1.10
Signs or Symptoms of Acute HIV Infection in a Cohort Undergoing Community-Based Screening. Emerg Infect Dis (2016) 1.09
Critical incidents of nonadherence with standard precautions guidelines among community hospital-based health care workers. J Gen Intern Med (2004) 1.09
Do changes in cigarette design influence the rise in adenocarcinoma of the lung? Cancer Causes Control (2010) 1.09
HIV-1 clade B pol evolution following primary infection. PLoS One (2013) 1.07
Risk Factors for Acute and Early HIV Infection Among Men Who Have Sex With Men (MSM) in San Diego, 2008 to 2014: A Cohort Study. Medicine (Baltimore) (2015) 1.05
Relationship of influenza vaccination declination statements and influenza vaccination rates for healthcare workers in 22 US hospitals. Infect Control Hosp Epidemiol (2008) 1.04
Unmet medical need in infectious diseases. Clin Infect Dis (2012) 1.00
Current management of prosthetic joint infections in adults: results of an Emerging Infections Network survey. Int J Antimicrob Agents (2013) 0.99
Practice patterns of infectious disease physicians for management of meningococcal disease. Pediatr Infect Dis J (2012) 0.99
Use of a pandemic preparedness drill to increase rates of influenza vaccination among healthcare workers. Infect Control Hosp Epidemiol (2008) 0.97
Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis. Diagn Microbiol Infect Dis (2006) 0.97
Trends in Clostridium difficile infection among peripartum women. Infect Control Hosp Epidemiol (2010) 0.96
Strategies to prevent healthcare-associated infections through hand hygiene. Infect Control Hosp Epidemiol (2014) 0.95
Epidemiology of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in a rural state. Infect Control Hosp Epidemiol (2006) 0.95
Upward trend in dengue incidence among hospitalized patients, United States. Emerg Infect Dis (2011) 0.95
Increased hospitalizations among sarcoidosis patients from 1998 to 2008: a population-based cohort study. BMC Pulm Med (2012) 0.95
Has the lung cancer risk from smoking increased over the last fifty years? Cancer Causes Control (2010) 0.93
Treatment approaches including fecal microbiota transplantation for recurrent Clostridium difficile infection (RCDI) among infectious disease physicians. Anaerobe (2013) 0.92
Streptococcus pneumoniae-associated hemolytic uremic syndrome among children in North America. Pediatr Infect Dis J (2011) 0.92
The effect of over-the-counter sales of the nicotine patch and nicotine gum on smoking cessation in California. Cancer Epidemiol Biomarkers Prev (2005) 0.92
Healthcare personnel perceptions of hand hygiene monitoring technology. Infect Control Hosp Epidemiol (2011) 0.91
Factors promoting consistent adherence to safe needle precautions among hospital workers. Infect Control Hosp Epidemiol (2004) 0.91
Should influenza immunisation be mandatory for healthcare workers? Yes. BMJ (2008) 0.91
Mitochondrial injury and cognitive function in HIV infection and methamphetamine use. AIDS (2016) 0.90
Primary stroke centers should be located using maximal coverage models for optimal access. Stroke (2012) 0.90
Influenza vaccination rates, feedback and the Hawthorne effect. Infect Control Hosp Epidemiol (2006) 0.90
Perspectives and concerns regarding antimicrobial agent shortages among infectious disease specialists. Diagn Microbiol Infect Dis (2013) 0.89
Cost savings associated with testing of antibodies, antigens, and nucleic acids for diagnosis of acute HIV infection. J Clin Microbiol (2012) 0.89
Comparison of the BACTEC 9240 and BacT/Alert blood culture systems for detection of bacterial contamination in platelet concentrates. J Clin Microbiol (2006) 0.89
Challenges in the management of infections due to carbapenem-resistant Enterobacteriaceae. Infect Control Hosp Epidemiol (2014) 0.88
Increasing telithromycin resistance among Streptococcus pyogenes in Europe. J Antimicrob Chemother (2008) 0.87
How many suffice? A computational framework for sizing sentinel surveillance networks. Int J Health Geogr (2013) 0.87
Does a failed quit attempt reduce cigarette consumption following resumption of smoking? The effects of time and quit attempts on the longitudinal analysis of self-reported cigarette smoking intensity. Nicotine Tob Res (2006) 0.87
Diagnosing and reporting of central line-associated bloodstream infections. Infect Control Hosp Epidemiol (2012) 0.86
The use of intravenous colistin among children in the United States: results from a multicenter, case series. Pediatr Infect Dis J (2013) 0.86
Protecting workers from secondhand smoke in North Carolina. N C Med J (2005) 0.85
Management of antimicrobial allergies by infectious diseases physicians. JAMA Intern Med (2013) 0.85
Impact of seminal cytomegalovirus replication on HIV-1 dynamics between blood and semen. J Med Virol (2012) 0.85
Automatic adverse drug events detection using letters to the editor. AMIA Annu Symp Proc (2012) 0.84
Do peer effects improve hand hygiene adherence among healthcare workers? Infect Control Hosp Epidemiol (2014) 0.84
Protease polymorphisms in HIV-1 subtype CRF01_AE represent selection by antiretroviral therapy and host immune pressure. AIDS (2010) 0.83
Characteristics of Staphylococcus aureus community-acquired pneumonia during the 2006-2007 influenza season. Clin Infect Dis (2007) 0.83
No evidence of posttreatment control after early initiation of antiretroviral therapy. AIDS (2015) 0.82
Results of a national survey of infectious diseases specialists regarding influenza vaccination programs for healthcare workers. Infect Control Hosp Epidemiol (2010) 0.82
HIV migration between blood and cerebrospinal fluid or semen over time. J Infect Dis (2013) 0.82
Treatment approaches to prosthetic joint infections: results of an Emerging Infections Network survey. Diagn Microbiol Infect Dis (2009) 0.81
Prevalence of beta-lactam nonsusceptible Gram-negative bacilli and use and interpretation of current susceptibility breakpoints: a survey of infectious disease physicians. Diagn Microbiol Infect Dis (2011) 0.81
Persistent neutrophilic meningitis in an immunocompetent patient after basilar skull fracture: case report. BMC Infect Dis (2011) 0.81
Pandemic (H1N1) 2009 Surveillance in Marginalized Populations, Tijuana, Mexico. Emerg Infect Dis (2010) 0.81